Andlauer Healthcare Group Inc.
ANDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $650,477 | $647,952 | $648,423 | $440,115 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Cost of Goods Sold | $503,273 | $500,471 | $489,576 | $329,361 |
| Gross Profit | $147,204 | $147,481 | $158,847 | $110,754 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $53,241 | $51,428 | $48,502 | $37,051 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$328 | $368 |
| Operating Expenses | $53,241 | $51,428 | $48,502 | $37,051 |
| Operating Income | $93,963 | $96,053 | $110,345 | $73,703 |
| % Margin | 14.4% | 14.8% | 17% | 16.7% |
| Other Income/Exp. Net | -$5,765 | -$5,446 | -$6,587 | $34,737 |
| Pre-Tax Income | $88,198 | $90,607 | $103,758 | $108,440 |
| Tax Expense | $23,730 | $24,467 | $27,483 | $18,486 |
| Net Income | $64,468 | $66,140 | $76,275 | $89,954 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS | 1.6 | 1.55 | 1.82 | 2.3 |
| % Growth | 3.2% | -14.8% | -20.9% | – |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| Weighted Avg Shares Out | 39,390 | 42,671 | 41,813 | 39,036 |
| Weighted Avg Shares Out Dil | 39,955 | 42,543 | 42,671 | 39,993 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,152 | $3,170 | $599 | $198 |
| Interest Expense | $7,585 | $8,207 | $6,858 | $6,219 |
| Depreciation & Amortization | $70,934 | $37,699 | $64,452 | $42,716 |
| EBITDA | $166,717 | $133,752 | $175,068 | $157,375 |
| % Margin | 25.6% | 20.6% | 27% | 35.8% |